Microorganisms,
Journal Year:
2019,
Volume and Issue:
7(4), P. 104 - 104
Published: April 11, 2019
Probiotics
per
definition
should
have
beneficial
effects
on
human
health,
and
their
consumption
has
tremendously
increased
in
the
last
decades.
In
parallel,
amount
of
published
material
claims
for
efficacy
soared
continuously.
Recently,
multiple
systemic
reviews,
meta-analyses,
expert
opinions
expressed
criticism
claimed
safety.
The
present
review
describes
dark
side
probiotics,
terms
problematic
research
design,
incomplete
reporting,
lack
transparency,
under-reported
Highlighted
are
potential
virulent
factors
mode
action
intestinal
lumen,
risking
physiological
microbiome
equilibrium.
Finally,
regulatory
topics
discussed
to
lighten
heterogeneous
guidelines
applied
worldwide.
shift
scientific
world
towards
a
better
understanding
microbiome,
before
probiotic
cargo,
is
highly
endorsed.
It
hoped
that
knowledge
will
extend
repertoire,
re-confirm
or
safety,
establish
substantiate
effects.
Journal of Translational Medicine,
Journal Year:
2019,
Volume and Issue:
17(1)
Published: Feb. 28, 2019
Gastrointestinal
microbiome
has
drawn
an
increasing
amount
of
attention
over
the
past
decades.
There
is
emerging
evidence
that
gut
flora
plays
a
major
role
in
pathogenesis
certain
diseases.
We
aimed
to
analyze
evolution
gastrointestinal
research
and
evaluate
publications
qualitatively
quantitatively.We
obtained
record
2891
manuscripts
published
between
1998
2018
from
Web
Science
Core
Collection
(WoSCC)
Thomson
Reuters;
this
was
on
June
23,
2018.
The
WoSCC
most
frequently
used
source
scientific
information.
term
"Gastrointestinal
Microbiomes"
all
its
hyponyms
retrieve
record,
restricted
subjects
gastroenterology
hepatology.
then
derived
clustered
network
70,169
references
were
cited
by
manuscripts,
identified
676
top
co-cited
articles.
Next,
we
bibliometric
method,
CiteSpace
V,
VOSviewer
1.6.8
identify
authors,
journals,
institutions,
countries,
keywords,
articles,
trends.We
number
time.
112
journals
articles
microbiome.
United
States
America
leading
country
for
publications,
institution
University
North
Carolina.
Co-cited
reference
analysis
revealed
landmark
field.
Gut
microbiota,
inflammatory
bowel
disease
(IBD),
probiotics,
irritable
disease,
obesity
are
some
high
frequency
keywords
co-occurrence
cluster
analysis;
indicating
microbiota
related
digestive
diseases
remain
hotspots
research.
Burst
detection
showed
bile
acid,
obesity,
Akkermansia
muciniphila
new
foci.This
study
our
understanding
link
associated
evolved
dramatically
therapeutic
targets
would
be
foci
future
Frontiers in Physiology,
Journal Year:
2023,
Volume and Issue:
14
Published: April 25, 2023
Mitochondria
play
a
key
role
in
both
health
and
disease.
Their
function
is
not
limited
to
energy
production
but
serves
multiple
mechanisms
varying
from
iron
calcium
homeostasis
the
of
hormones
neurotransmitters,
such
as
melatonin.
They
enable
influence
communication
at
all
physical
levels
through
interaction
with
other
organelles,
nucleus,
outside
environment.
The
literature
suggests
crosstalk
between
mitochondria
circadian
clocks,
gut
microbiota,
immune
system.
might
even
be
hub
supporting
integrating
activity
across
these
domains.
Hence,
they
(missing)
link
Mitochondrial
dysfunction
related
metabolic
syndrome,
neuronal
diseases,
cancer,
cardiovascular
infectious
inflammatory
disorders.
In
this
regard,
diseases
Alzheimer’s,
Parkinson’s,
amyotrophic
lateral
sclerosis
(ALS),
chronic
fatigue
syndrome
(CFS),
pain
are
discussed.
This
review
focuses
on
understanding
mitochondrial
action
that
allow
for
maintenance
pathways
toward
dysregulated
mechanisms.
Although
have
allowed
us
adapt
changes
over
course
evolution,
turn,
evolution
has
shaped
mitochondria.
Each
evolution-based
intervention
influences
its
own
way.
use
physiological
stress
triggers
tolerance
stressor,
achieving
adaptability
resistance.
describes
strategies
could
recover
functioning
providing
comprehensive,
root-cause-focused,
integrative
approach
recovering
treating
people
suffering
diseases.
BMC Medicine,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: March 13, 2024
Abstract
Background
Previous
randomized
controlled
trials
(RCTs)
suggested
that
gut
microbiota-based
therapies
may
be
effective
in
treating
autoimmune
diseases,
but
a
systematic
summary
is
lacking.
Methods
Pubmed,
EMbase,
Sinomed,
and
other
databases
were
searched
for
RCTs
related
to
the
treatment
of
diseases
with
probiotics
from
inception
June
2022.
RevMan
5.4
software
was
used
meta-analysis
after
2
investigators
independently
screened
literature,
extracted
data,
assessed
risk
bias
included
studies.
Results
A
total
80
14
types
disease
[celiac
sprue,
SLE,
lupus
nephritis
(LN),
RA,
juvenile
idiopathic
arthritis
(JIA),
spondyloarthritis,
psoriasis,
fibromyalgia
syndrome,
MS,
systemic
sclerosis,
type
1
diabetes
mellitus
(T1DM),
oral
lichen
planus
(OLP),
Crohn’s
disease,
ulcerative
colitis]
included.
The
results
showed
improve
symptoms
and/or
inflammatory
factor
celiac
SLE
LN,
JIA,
PSS,
colitis.
However,
not
spondyloarthritis
RA.
Gut
relieve
pain
effect
on
impact
questionnaire
score
significant.
HbA1c
T1DM,
its
insulin
requirement
does
seem
These
did
increase
incidence
adverse
events.
Conclusions
several
(celiac
colitis).
Journal of Food Biochemistry,
Journal Year:
2024,
Volume and Issue:
2024, P. 1 - 23
Published: Feb. 7, 2024
Probiotics
have
growing
medical
importance
as
a
result
of
their
potential
in
the
prevention
and
therapeutic
support
several
complex
diseases,
including
different
types
cancers.
The
anticarcinogenic
properties
probiotics
are
attributed
to
various
mechanisms,
alterations
composition
intestinal
microbiota,
suppression
cell
proliferation,
stimulation
apoptosis,
inhibition
NF-kB,
reduction
levels
H2AX,
8-hydroxy-deoxyguanosine,
RIG-I,
downregulation
IL-17,
TNF
signaling
pathway.
Furthermore,
demonstrated
significant
advantages
management
other
diabetes,
obesity,
cardiovascular
diseases.
had
considerable
effect
reducing
inflammatory
infiltration
occurrence
precancerous
lesions.
Additionally,
administration
led
decrease
appearance
level
genes
related
proinflammatory
pathways,
NF-κB,
pathways.
However,
further
research
studies
required
comprehend
processes
via
which
exert
effects
authenticate
alternative
interventions.
Nutrients,
Journal Year:
2018,
Volume and Issue:
10(10), P. 1537 - 1537
Published: Oct. 18, 2018
Probiotics
have
been
used
to
ameliorate
gastrointestinal
symptoms
since
ancient
times.
Over
the
past
40
years,
probiotics
shown
impact
immune
system,
both
in
vivo
and
vitro.
This
interaction
is
linked
gut
microbes,
their
polysaccharide
antigens,
key
metabolites
produced
by
these
bacteria.
At
least
four
metabolic
pathways
implicated
mechanistic
studies
of
probiotics,
based
on
animal
models.
Microbial⁻immune
system
crosstalk
has
to:
short-chain
fatty
acid
production
signaling,
tryptophan
metabolism
activation
aryl
hydrocarbon
receptors,
nucleoside
signaling
gut,
intestinal
histamine-2
receptor.
Several
randomized
controlled
trials
now
that
microbial
modification
may
improve
multiorgan
inflammation
rheumatoid
arthritis,
ulcerative
colitis,
multiple
sclerosis.
Future
work
will
need
carefully
assess
safety
issues,
selection
optimal
strains
combinations,
attempts
prolong
duration
colonization
beneficial
microbes.
Experimental & Molecular Medicine,
Journal Year:
2019,
Volume and Issue:
51(12), P. 1 - 6
Published: Dec. 1, 2019
Abstract
The
gut
microbiota
has
been
proposed
to
be
an
important
environmental
factor
in
the
development
of
rheumatoid
arthritis
(RA).
Here,
we
review
a
growing
body
evidence
from
human
and
animal
studies
that
supports
hypothesis
intestinal
play
role
RA.
Previous
others
showed
altered
composition
early
RA
patients.
A
recent
study
demonstrated
Prevotella
species
are
dominant
intestine
patients
preclinical
stages
In
addition,
-dominated
isolated
contributes
Th17
cell-dependent
SKG
mice.
Moreover,
it
was
reported
periodontal
bacteria
correlates
with
pathogenesis
this
review,
discuss
link
between
oral
arthritis.
However,
many
questions
remain
elucidated
terms
molecular
mechanisms
for
involvement
pathogenesis.
Mediators of Inflammation,
Journal Year:
2018,
Volume and Issue:
2018, P. 1 - 17
Published: Jan. 1, 2018
The
gut
environment
and
microbiome
dysbiosis
have
been
demonstrated
to
significantly
influence
a
range
of
disorders
in
humans,
including
obesity,
diabetes,
rheumatoid
arthritis,
multiple
sclerosis
(MS).
MS
is
an
autoimmune
disease
affecting
the
central
nervous
system
(CNS).
etiology
not
clear,
it
should
involve
both
genetic
extrinsic
factors.
factors
responsible
for
predisposition
remain
elusive.
Recent
studies
on
its
animal
model,
experimental
encephalomyelitis
(EAE),
found
that
gastrointestinal
microbiota
may
play
important
role
pathogenesis
MS/EAE.
Thus,
adjustment
be
future
direction
treatment
MS.
In
this
review,
we
discuss
characteristics
microbiota,
connection
between
brain
gut,
changes
MS/EAE,
explore
possibility
applying
therapies
patients
with
Frontiers in Immunology,
Journal Year:
2020,
Volume and Issue:
10
Published: Jan. 10, 2020
Environmental
agents
have
gained
much
attention
in
recent
years
for
their
role
triggering
autoimmune
diseases
(ADs).
Increasing
evidence
has
linked
environmental
exposures,
including
trichloroethene
(TCE),
silica,
mercury,
pristane,
pesticides
and
smoking
to
higher
risk
ADs.
However,
potential
mechanisms
by
which
these
contribute
the
disease
pathogenesis
remains
largely
unknown.
Dysbiosis
of
gut
microbiome
is
another
important
factor
that
been
onset
different
Altered
microbiota
composition
associated
with
impaired
intestinal
barrier
function
dysregulation
mucosal
immune
system,
but
it
unclear
if
dysbiosis
a
causal
or
an
outcome
In
this
review
article,
we
first
describe
epidemiological
mechanistic
evidences
linking
environmental/occupational
exposures
various
ADs
(especially
SLE).
Secondly,
discuss
how
changes
(dysbiosis)
could
pathogenesis,
especially
response
exposure
chemicals.